We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TCON market cap is 56.43M. The company's latest EPS is USD -0.0788 and P/E is -15.74.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 9M | 0 | 3.05M | 100k |
Operating Income | -7.31M | -779k | -1.59M | 407k | -3.21M |
Net Income | -8.5M | -6.29M | 10.76M | 439k | -3.17M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 346k | 0 | 12.05M |
Operating Income | -22.3M | -16.22M | -28.35M | -27.89M | -9.27M |
Net Income | -22.67M | -16.78M | -28.67M | -29.14M | -3.59M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.32M | 12.19M | 9.41M | 10.11M | 9.36M |
Total Liabilities | 19.4M | 27.93M | 12.5M | 10.91M | 11.12M |
Total Equity | -11.07M | -15.74M | -3.08M | -809k | -1.76M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 18.12M | 37.44M | 26.56M | 19.47M | 10.11M |
Total Liabilities | 15.42M | 12.37M | 14.84M | 26.62M | 10.91M |
Total Equity | 2.7M | 25.07M | 11.71M | -7.15M | -809k |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -5M | -10.85M | 4.2M | 3.68M | -2.54M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | -5.82M | -4.77M | -13.86M | -12.54M | 1.87M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -23.65M | -17.04M | -22.57M | -26.24M | 3.68M |
Investing | 14.02M | -4M | 3.95M | -17k | N/A |
Financing | 906k | 36.76M | 10.56M | 19.68M | -12.54M |
Market Cap | 56.43M |
Price to Earnings Ratio | -15.74 |
Price to Sales Ratio | 4.68 |
Price to Cash Ratio | 6.59 |
Price to Book Ratio | -69.75 |
Dividend Yield | - |
Shares Outstanding | 45.5M |
Average Volume (1 week) | 296.53k |
Average Volume (1 Month) | 142.71k |
52 Week Change | -88.66% |
52 Week High | 14.746 |
52 Week Low | 0.6949 |
Spread (Intraday) | 0.29 (19.08%) |
Company Name | TRACON Pharmaceuticals Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.traconpharma.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions